`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MYLAN PHARMACEUTICALS INC., CELLTRION, INC., and
`APOTEX, INC.,
`Petitioners,
`
`
`
`v.
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner.
`
`
`Inter Partes Review No.: IPR2021-008811
`
`
`U.S. Patent No. 9,254,338 B2
`Filed: July 12, 2013
`Issued: February 9, 2016
`Inventor: George D. Yancopoulos
`
`Title: USE OF A VEGF ANTAGONIST TO TREAT
`ANGIOGENIC EYE DISORDERS
`
`
`Petitioner’s Amended Mandatory Notices
`
`
`
`
`
`
`1 IPR2022-00258 and IPR2022-00298 have been joined with this proceeding.
`
`
`
`
`
`Mylan Pharmaceuticals Inc. (“Petitioner”) submits the following amended
`
`mandatory notices to identify additional related matters and real parties-in-interest.
`
` REAL PARTIES-IN-INTEREST (37 C.F.R. § 42.8(b)(1)) (AMENDED).
`Viatris Inc. and Mylan Inc. are parent companies of Petitioner Mylan
`
`Pharmaceuticals Inc.
`
` Accordingly, Viatris Inc., Mylan Inc., and Mylan
`
`Pharmaceuticals Inc. are identified as real parties-in-interest to the current Petition.
`
`Momenta Pharmaceuticals, Inc. and Janssen Research & Development LLC are
`
`wholly-owned
`
`subsidiaries of
`
`Johnson &
`
`Johnson, a publicly held
`
`company. Momenta Pharmaceuticals, Inc., Janssen Research & Development LLC,
`
`and Johnson & Johnson are also real parties-in-interest to the current Petition.
`
`Biocon Limited, Biocon Biologics Limited, Biocon Biologics UK Limited, and
`
`Biosimilar Collaborations Ireland Limited are also real parties-in-interest to the
`
`current Petition. Biocon Biologics Limited is a subsidiary of Biocon Limited, a
`
`publicly traded company. Biocon Biologics UK Limited is a wholly owned
`
`subsidiary of Biocon Biologics Limited, and Biosimilar Collaborations Ireland
`
`Limited is a wholly owned subsidiary of Biocon Biologics UK Limited. No other
`
`parties exercised or could have exercised control over this Petition; no other parties
`
`funded, directed and controlled this Petition. See Trial Practice Guide, 77 Fed. Reg.
`
`48759-60 (Aug. 14, 2021).
`
`
`
` RELATED MATTERS (37 C.F.R. § 42.8(b)(2)) (AMENDED).
`Petitioner identifies Mylan Pharms. Inc. v. Regeneron Pharms., Inc., No.
`
`IPR2021-00880 (P.T.A.B.). Petitioner also identifies Mylan Pharms. Inc. v.
`
`Regeneron Pharms., Inc., No. IPR2022-01225 (P.T.A.B.), Mylan Pharms. Inc. v.
`
`Regeneron Pharms., Inc., No. IPR2022-01226 (P.T.A.B.), Mylan Pharms. Inc. v.
`
`Regeneron Pharms., Inc., No. IPR2023-00099 (P.T.A.B.), and Regeneron Pharms.,
`
`Inc. v. Mylan Pharms. Inc., 1:22-cv-00061-TSK (N.D.W. Va.). To the best of
`
`Petitioner’s knowledge, the following are additional judicial or administrative
`
`matters that would affect, or be affected by, a decision in this proceeding: Apotex
`
`Inc. v. Regeneron Pharmaceuticals, Inc., No. IPR2022-01524 (P.T.A.B.), United
`
`States v. Regeneron Pharms., Inc., No. 1:20-cv-11217-FDS (D. Mass.), and Horizon
`
`Healthcare Servs., Inc. v. Regeneron Pharms., Inc., No. 1:22-cv-10493-FDS (D.
`
`Mass.). Petitioner further identifies Chengdu Kanghong Biotechnology Co. v.
`
`Regeneron Pharms., Inc., No. PGR2021-00035 (P.T.A.B.) out of an abundance of
`
`caution.
`
`U.S. Patent Nos. 9,669,069 B2, 10,130,681 B2, 10,857,205 B2, 10,828,345
`
`B2, 10,888,601 B2, and 11,253,572 B2; and U.S. Patent Application Nos.
`
`17/072,417, 17/112,063, 17/112,404, 17/350,958, and 17/740,744 claim the benefit
`
`of the ’338 patent filing date.
`
`2
`
`
`
` LEAD AND BACK-UP COUNSEL AND SERVICE INFORMATION (37
`C.F.R. § 42.8(b)(3)-(4)).
`Petitioner identifies its lead and backup counsel below.
`
`Lead
`
`Back-Up
`
`Paul J. Molino (Reg. No. 45,350)
`paul@rmmslegal.com
`
`Postal and Hand Delivery Address
`Rakoczy Molino Mazzochi Siwik LLP
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone: (312) 222-6300
`Facsimile: (312) 843-6260
`
`Petitioner consents to email service at:
`MYL_REG_IPR@rmmslegal.com
`
`
`William A. Rakoczy
`(admitted pro hac vice)
`wrakoczy@rmmslegal.com
`
`Deanne M. Mazzochi (Reg. No. 50,158)
`dmazzochi@rmmslegal.com
`
`Heinz J. Salmen
`(admitted pro hac vice)
`hsalmen@rmmslegal.com
`
`Jeff A. Marx (Reg. No. 56,977)
`jmarx@rmmslegal.com
`
`Eric R. Hunt
`(admitted pro hac vice)
`ehunt@rmmslegal.com
`
`Neil B. McLaughlin (Reg. No. 70,810)
`nmclaughlin@rmmslegal.com
`
`L. Scott Beall (Reg. No. 52,601)
`sbeall@rmmslegal.com
`
`Thomas H. Ehrich (Reg. No. 67,122)
`tehrich@rmmslegal.com
`
`Steven J. Birkos (Reg. No. 65,300)
`sbirkos@rmmslegal.com
`
`Postal and Hand Delivery Address
`Rakoczy Molino Mazzochi Siwik LLP
`
`3
`
`
`
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone: (312) 527-2157
`Facsimile: (312) 843-6260
`
`
`
`
`Please direct all correspondence to lead and back-up counsel at the contact
`
`information above.
`
` Petitioner also consents
`
`to service by email at:
`
`MYL_REG_IPR@rmmslegal.com.
`
`
`
`
`Dated: December 29, 2022
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`
`/Paul J. Molino/
`Paul J. Molino
`Registration No. 45,350
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone:
`(312) 222-6300
`Facsimile:
`(312) 843-6260
`paul@rmmslegal.com
`
`
`Counsel for Petitioner
`
`
`
`
`
`4
`
`
`
`
`
`CERTIFICATE OF SERVICE
`The undersigned hereby certifies that a true and correct copy of the foregoing
`
`Petitioner’s Amended Mandatory Notices was served on December 29, 2022, via
`
`electronic mail, to the following counsel of record for Patent Owner:
`
`Deborah E. Fishman (Reg. No. 48,621)
`David A. Caine (Reg. No. 52,683)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Telephone: 650.319.4710
`Facsimile: 650.319.4573
`Deborah.Fishman@arnoldporter.com
`David.Caine@arnoldporter.com
`RegeneronEyleaIPRs@arnoldporter.com
`
`Alice S. Ho (Lim. Rec. No. L1162)
`Victoria Reines
`Jeremy Cobb
`Arnold & Porter Kaye Scholer LLP
`601 Massachusetts Ave., N.W.
`Washington D.C. 20001
`Tel: 202.942.5000
`Fax: 202.942.5999
`Alice.Ho@arnoldporter.com
`Victoria.Reines@arnoldporter.com
`Jeremy.Cobb@arnoldporter.com
`
`
`Respectfully Submitted,
`
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`
`/Paul J. Molino/
`
`Daniel Reisner
`Matthew M. Wilk
`Arnold & Porter Kaye Scholer LLP
`250 West 55th Street
`New York, New York 10019-9710
`Telephone: 212.836.8000
`Fax: 212.836.8689
`Daniel.Reisner@arnoldporter.com
`Matthew.Wilk@arnoldporter.com
`
`
`
`Dated: December 29, 2022
`
`
`
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
